Literature DB >> 18650828

Peyronie's disease: a critical appraisal of current diagnosis and treatment.

J F Smith1, T J Walsh, T F Lue.   

Abstract

Peyronie's disease is a fibrotic disorder of the tunica albuginea of the penis resulting in varying degrees of penile curvature and sexual dysfunction. Diagnosis of the disorder is made by detailed sexual history and focused physical examination. A wide range of medical treatments has been employed to treat the disorder. Verapamil treatment administered by intraplaque injection is supported by generally consistent randomized controlled trials (RCT). Some RCT evidence exists to support the use of colchicine, potaba, L-carnitine and liposomal superoxide dismutase. Future studies of medical efficacy should focus on improving RCT design, implementation and results reporting to improve the quality of evidence generated by each study. The surgical treatment of Peyronie's disease is a viable and recommended alternative for men with compromised sexual function due to severe curvature or lesions causing penile instability. The choice of corrective procedure should be tailored to each patient after a detailed evaluation of disease severity and sexual function.

Entities:  

Mesh:

Year:  2008        PMID: 18650828     DOI: 10.1038/ijir.2008.30

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  16 in total

Review 1.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

2.  Penile prosthesis implantation and tunica albuginea incision without grafting in the treatment of Peyronie's disease with erectile dysfunction.

Authors:  Miroslav L Djordjevic; Vladimir Kojovic
Journal:  Asian J Androl       Date:  2013-02-25       Impact factor: 3.285

3.  Geometrical modified nesbit corporoplasty to correct different types of penile curvature: description of the surgical procedure based on geometrical principles and long-term results.

Authors:  P Vicini; S Di Nicola; G Antonini; E De Berardinis; V Gentile; F De Marco
Journal:  Int J Impot Res       Date:  2016-08-11       Impact factor: 2.896

Review 4.  Current status of the surgical management of Peyronie's disease.

Authors:  Ates Kadioglu; Faruk Küçükdurmaz; Oner Sanli
Journal:  Nat Rev Urol       Date:  2011-02       Impact factor: 14.432

5.  Male Sexual Dysfunction.

Authors:  Danyon Anderson; John Laforge; Maggie M Ross; Robert Vanlangendonck; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-08-20

6.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

7.  A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States.

Authors:  Dana Britt Dibenedetti; Dat Nguyen; Laurie Zografos; Ryan Ziemiecki; Xiaolei Zhou
Journal:  Adv Urol       Date:  2011-10-23

8.  Current and emerging treatment options for Peyronie's disease.

Authors:  Ahmet Gokce; Julie C Wang; Mary K Powers; Wayne Jg Hellstrom
Journal:  Res Rep Urol       Date:  2013-01-14

9.  Pro: does shockwave therapy have a place in the treatment of Peyronie's disease?

Authors:  Eric Chung
Journal:  Transl Androl Urol       Date:  2016-06

Review 10.  Grafting techniques for Peyronie's disease.

Authors:  Georgios Hatzichristodoulou
Journal:  Transl Androl Urol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.